bhavana

The report " Gastrointestinal Therapeutics Market by Drug Glass (Antacids, Laxatives, Antidiarrheal agents, Antiemetics, Antiulcer agents, and Others), by Mode of Administration (Oral, Intravenous, and Others), by Application (Gastroenteritis, Gastrointestinal Bleeding, Irritable Bowel Syndrome, and Peptic Ulcer Disease), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and others ), - Global Forecasts to 2030" The global Gastrointestinal Therapeutics Market is projected to reach USD 53.8 billion in 2023, registering at a Compound Annual Growth Rate (CAGR) of 7.9% during the forecast period 2024-2030. therapy. Request sample report at https://www.precisionbusinessinsights.com/request-sample/?product_id=37257 Competitive Dashboard: The prominent key players operating in the global Gastrointestinal Therapeutics Market Abbott Laboratories (US) Allergan (Ireland) AstraZeneca plc (UK) GlaxoSmithKline Plc (UK) Takeda Pharmaceutical Company Li...

The global gastrointestinal therapeutics market size was valued at USD 52.8 billion in 2022 and is poised to grow at a significant CAGR of 6.9% during the forecast period 2023-29. It also includes market size and projection estimations for each of the five major regions from 2023 to 2029. The research report includes historical data, trending features, and market growth estimates for the future. Furthermore, the study includes a global and regional estimation and further split by nations and categories within each region. The research also includes factors and barriers to the  gastrointestinal therapeutics market growth , as well as their impact on the market's future growth. The report gives a comprehensive overview of both primary and secondary data.    View the detailed report description here -  https://www.precisionbusinessinsights.com/market-reports/gastrointestinal-therapeutics-market The global gastrointestinal therapeutics market segmentation: 1. By Drug Gla...